Possible Mechanisms of Lymphoma Development in Sjogren’s Syndrome
Open Access
- 1 June 2013
- journal article
- Published by Bentham Science Publishers Ltd. in Current Immunology Reviews
- Vol. 9 (1) , 13-22
Abstract
Primary Sjögren’s syndrome (pSS) is a systemic as well as an organ-specific autoimmune disease characterized by lymphocytic infiltration of the glandular epithelial tissue. SS patients have been reported to be at highest risk of developing lymphoproliferative neoplasms, when compared with patients with other rheumatoid diseases. Factors such as cytokine stimulation, environmental factors, viral infection and genetic events as well as vitamin deficiency may contribute to the development of lymphoma. Over the past few decades, numerous efforts have been made to assess the relationship between lymphoma and SS. These include epidemiological surveys, molecular biologic assessments of clonality and well-linked register cohort studies evaluating the predictive value of clinical, laboratory and histological findings. Nevertheless, the mechanisms and factors predictive of lymphoma development in pSS patients remain to be defined. This review summarizes updated knowledge on the incidence of and risk factors for lymphoma development in pSS patients, as well as discussing the most recent findings on the development and treatment of lymphoma in pSS patients and the possible mechanism of lymphoma development.Keywords
This publication has 99 references indexed in Scilit:
- Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2011
- What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?Arthritis Research & Therapy, 2011
- Polymerase chain reaction (PCR) detection of B cell clonality in Sjögren's syndrome patients: a diagnostic tool of clonal expansionClinical and Experimental Immunology, 2010
- Population‐based study of autoimmune conditions and the risk of specific lymphoid malignanciesInternational Journal of Cancer, 2009
- Controversies on Rituximab Therapy in Sjögren Syndrome-Associated LymphoproliferationInternational Journal of Rheumatology, 2009
- Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph ConsortiumBlood, 2008
- Association of an IRF5 gene functional polymorphism with Sjögren's syndromeArthritis & Rheumatism, 2007
- Clonality analysis of lymphoproliferative disorders in patients with Sjögren's syndromeClinical and Experimental Immunology, 2007
- Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2007
- Lymphoma and other malignancies in primary Sjögren's syndromeAnnals of the Rheumatic Diseases, 2006